SOUTHWEST ONCOLOGY GROUP
SOUTHWEST ONCOLOGY GROUP
批准号:
6854994
负责人:
LAWRENCE E FLAHERTY
金额:
$8.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2004-03-31
关键词:
antineoplasticsbleomycinbone marrow transplantationbrain neoplasmsbreast neoplasmscancer information systemcancer preventioncancer registry /resourcecis platinum compoundclinical researchclinical trialscombination cancer therapycombination chemotherapycooperative studycyclophosphamidedoxorubicindrug resistancefemale reproductive system neoplasmfludarabinegastrointestinal neoplasmshead /neck neoplasmhormone therapyhuman subjecthuman therapy evaluationifosfamideleukemialung neoplasmslymphomameeting /conference /symposiummelanomamultiple myelomaneoplasm /cancer chemotherapyneoplasm /cancer diagnosisneoplasm /cancer epidemiologyneoplasm /cancer geneticsneoplasm /cancer immunotherapyneoplasm /cancer radiation therapyneoplasm /cancer surgeryoncology nursingpaclitaxelpancreas neoplasmspathologyprognosisprostate neoplasmsquality of lifesarcomatamoxifentissue resource /registryurinary tract neoplasmswomen&aposs health
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Description (Adapted from the applicant's abstract): Wayne State University
(WSU) has been an active institutional member of the Southwest Oncology
Group for over 25 years, enrolling over 4500 patients onto clinical trials.
Over these years, their faculty have played an important role in support of
SWOG, by providing leadership in the administrative and scientific functions
of SWOG, and also by meeting and exceeding patient accrual goals in a
continuous and consistent manner. Thus, WSU has remained in the first
quartile of institution's performance evaluation conducted by SWOG in each
of the last five years. The clinical research program in cancer at WSU has
been organized along the lines of multidisciplinary disease oriented studies
and in a manner which resembles the organ committee orientation of SWOG.
Thus, their faculty's representation in scientific SWOG committees is
constituted by individuals with expertise and commitment towards those areas
of research. Accordingly, the translation of ideas into SWOG studies as
well as the incorporation of SWOG studies and those of NCI designated high
priority trials into WSU treatment priorities, are easily facilitated. In
addition, the demographics of their region and the commitment of
investigators to make clinical trials available to all patients, is clearly
identified in their recruitment of minorities (33 percent) and women (46
percent) into SWOG clinical trials. The SWOG membership in WSU and the
diversity of disciplinary involvement by their faculty has continued to grow
over the years. To date, 87 WSU members are currently serving on 38
committees. Similarly, 60 SWOG studies list a WSU member as a study
chairman or as study coordinator since the last competing application was
submitted. Dr. Lawrence Flaherty, a SWOG member since 1986 and
Vice-Chairman of the SWOG Melanoma Committee, becomes the Principal
Investigator of this competing renewal at the departure of Dr. Manuel
Valdivieso for another institution. He will maintain the prominence of WSU
as a SWOG member institution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NCI National Clinical Trials Network – Network Lead Academic Participating Site
-
批准号:10357935
-
项目类别:
-
资助金额:$51.87万
-
财政年份:2019
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
NCI National Clinical Trials Network – Network Lead Academic Participating Site
-
批准号:9886223
-
项目类别:
-
资助金额:$50.54万
-
财政年份:2019
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
NCI National Clinical Trials Network – Network Lead Academic Participating Site
-
批准号:10579865
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2019
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
NCI National Clinical Trials Network-Network Lead Academic Participating Site
-
批准号:8842111
-
项目类别:
-
资助金额:$60.27万
-
财政年份:2014
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
NCI National Clinical Trials Network-Network Lead Academic Participating Site
-
批准号:8605744
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2014
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
NCI National Clinical Trials Network-Network Lead Academic Participating Site
-
批准号:9023510
-
项目类别:
-
资助金额:$60.21万
-
财政年份:2014
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Clinical Trials Office
-
批准号:8350787
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2011
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10348671
-
项目类别:
-
资助金额:$11.01万
-
财政年份:1997
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10553200
-
项目类别:
-
资助金额:$10.65万
-
财政年份:1997
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10088985
-
项目类别:
-
资助金额:$10.23万
-
财政年份:1997
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
SOUTHWEST ONCOLOGY GROUP
-
批准号:2086197
-
项目类别:
-
资助金额:$30.67万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group
-
批准号:7405339
-
项目类别:
-
资助金额:$21.72万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group
-
批准号:7050113
-
项目类别:
-
资助金额:$20.78万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group U10 Member Site
-
批准号:8075449
-
项目类别:
-
资助金额:$34.96万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group
-
批准号:7563950
-
项目类别:
-
资助金额:$22.1万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group U10 Member Site
-
批准号:7766863
-
项目类别:
-
资助金额:$33.26万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
SOUTHWEST ONCOLOGY GROUP
-
批准号:2007161
-
项目类别:
-
资助金额:$30.46万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group U10 Member Site
-
批准号:8410591
-
项目类别:
-
资助金额:$33.18万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
Southwest Oncology Group
-
批准号:7487667
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
SOUTHWEST ONCOLOGY GROUP
-
批准号:6341815
-
项目类别:
-
资助金额:$31.95万
-
财政年份:1978
-
负责人:LAWRENCE E FLAHERTY
-
依托单位:
海外基金